BrainStorm to Host Tomorrow a Conference Call to Announce Its "Right To Try" Policy
BrainStorm to Host Tomorrow a Conference Call to Announce Its "Right To Try" Policy Conference Call and Live Webcast at 8:30am Eastern Time |
[25-June-2018] |
NEW YORK and PETACH TIKVAH, Israel, June 25, 2018 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, will hold a conference call tomorrow, June 26th at 08:30am Eastern Time, to announce its policy in regards to the "Right To Try" legislation.
About BrainStorm Cell Therapeutics Inc. CONTACTS Media: Media: Investors: View original content with multimedia:http://www.prnewswire.com/news-releases/brainstorm-to-host-tomorrow-a-conference-call-to-announce-its-right-to-try-policy-300671492.html SOURCE BrainStorm Cell Therapeutics Inc. | ||||||||
Company Codes: NASDAQ-SMALL:BCLI |
© 2018 PR Newswire. All Rights Reserved.
#content-news .main-news{color:#737373;font-size:14px;line-height:inherit;text-align:inherit}